Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 20;21(1):47.
doi: 10.1186/s12938-022-01018-2.

Application of artificial intelligence-based dual-modality analysis combining fundus photography and optical coherence tomography in diabetic retinopathy screening in a community hospital

Affiliations

Application of artificial intelligence-based dual-modality analysis combining fundus photography and optical coherence tomography in diabetic retinopathy screening in a community hospital

Rui Liu et al. Biomed Eng Online. .

Abstract

Background: To assess the feasibility and clinical utility of artificial intelligence (AI)-based screening for diabetic retinopathy (DR) and macular edema (ME) by combining fundus photos and optical coherence tomography (OCT) images in a community hospital.

Methods: Fundus photos and OCT images were taken for 600 diabetic patients in a community hospital. Ophthalmologists graded these fundus photos according to the International Clinical Diabetic Retinopathy (ICDR) Severity Scale as the ground truth. Two existing trained AI models were used to automatically classify the fundus images into DR grades according to ICDR, and to detect concomitant ME from OCT images, respectively. The criteria for referral were DR grades 2-4 and/or the presence of ME. The sensitivity and specificity of AI grading were evaluated. The number of referable DR cases confirmed by ophthalmologists and AI was calculated, respectively.

Results: DR was detected in 81 (13.5%) participants by ophthalmologists and in 94 (15.6%) by AI, and 45 (7.5%) and 53 (8.8%) participants were diagnosed with referable DR by ophthalmologists and by AI, respectively. The sensitivity, specificity and area under the curve (AUC) of AI for detecting DR were 91.67%, 96.92% and 0.944, respectively. For detecting referable DR, the sensitivity, specificity and AUC of AI were 97.78%, 98.38% and 0.981, respectively. ME was detected from OCT images in 49 (8.2%) participants by ophthalmologists and in 57 (9.5%) by AI, and the sensitivity, specificity and AUC of AI were 91.30%, 97.46% and 0.944, respectively. When combining fundus photos and OCT images, the number of referrals identified by ophthalmologists increased from 45 to 75 and from 53 to 85 by AI.

Conclusion: AI-based DR screening has high sensitivity and specificity and may feasibly improve the referral rate of community DR.

Keywords: Artificial intelligence; Deep learning; Diabetic retinopathy; Optical coherence tomography.

PubMed Disclaimer

Conflict of interest statement

The authors have no proprietary or commercial interest in any materials discussed in this article.

Figures

Fig. 1
Fig. 1
OCT-Fundus-AI diagnosis results. a OCT B-scan with detection of retinal fluid (purple bounding box). b OCT B-scan with detection of the epiretinal membrane (yellow bounding box). c No obvious abnormalities on the fundus
Fig. 2
Fig. 2
a Comparison of diabetic retinopathy (DR) grading between ophthalmologists and AI. b The confusion matrix for the DR detection. c Comparison of macular edema (ME) classifications between ophthalmologists and AI. d The confusion matrix for the ME detection
Fig. 3
Fig. 3
Venn diagram showing the overlap comparison of the number of referrals between human and automated grading: a fundus photography, b OCT, and c fundus photography combined with OCT
Fig. 4
Fig. 4
Flowchart of AI-based dual-modality DR screening algorithm
Fig. 5
Fig. 5
Examples of classification heatmaps of different levels of DR
Fig. 6
Fig. 6
Retinal abnormality detection results. Detected retinal exudates (white bounding box) and retinal fluid (purple bounding box)

Similar articles

Cited by

References

    1. Teo ZL, Tham YC, Yu M, Cheng CY, Wong TY, Sabanayagam C. Do we have enough ophthalmologists to manage vision-threatening diabetic retinopathy? A global perspective. Eye. 2020;34(7):1255–1261. doi: 10.1038/s41433-020-0776-5. - DOI - PMC - PubMed
    1. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi: 10.2337/dc11-1909. - DOI - PMC - PubMed
    1. Leasher JL, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, Pesudovs K, Price H, White RA, Wong TY, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care. 2016;39(9):1643–1649. doi: 10.2337/dc15-2171. - DOI - PubMed
    1. Doi K. Diagnostic imaging over the last 50 years: research and development in medical imaging science and technology. Phys Med Biol. 2006;51(13):R5–27. doi: 10.1088/0031-9155/51/13/R02. - DOI - PubMed
    1. Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW. Diabetic retinopathy: a position statement by the american diabetes association. Diabetes Care. 2017;40(3):412–418. doi: 10.2337/dc16-2641. - DOI - PMC - PubMed

MeSH terms